Ngā hua rapu - Ernest Asante‐Appiah

  • E whakaatu ana i te 1 - 8 hua o te 8
Whakamahine hua
  1. 1
    Protein Tyrosine Phosphatase-1B Dephosphorylation of the Insulin Receptor Occurs in a Perinuclear Endosome Compartment in Human Embryonic Kidney 293 Cells

    Protein Tyrosine Phosphatase-1B Dephosphorylation of the Insulin Receptor Occurs in a Perinuclear Endosome Compartment in Human Embryonic Kidney 293 Cells mā Yolanda Romsicki, Mark Reece, J. Y. GAUTHIER, Ernest Asante‐Appiah, Brian P. Kennedy

    I whakaputaina 2004
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Islatravir Has a High Barrier to Resistance and Exhibits a Differentiated Resistance Profile from Approved Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

    Islatravir Has a High Barrier to Resistance and Exhibits a Differentiated Resistance Profile from Approved Nucleoside Reverse Transcriptase Inhibitors (NRTIs) mā Tracy L. Diamond, Winnie Ngo, Min Xu, Shih Lin Goh, Silveria Rodriguez, Ming‐Tain Lai, Ernest Asante‐Appiah, Jay A. Grobler

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Review of Doravirine Resistance Patterns Identified in Participants During Clinical Development

    Review of Doravirine Resistance Patterns Identified in Participants During Clinical Development mā Elizabeth A. Martin, Ming‐Tain Lai, Winnie Ngo, Meizhen Feng, Donald J. Graham, Daria J. Hazuda, Sushma Kumar, Carey Hwang, Peter Sklar, Ernest Asante‐Appiah

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors

    Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors mā David R. McGivern, Takahiro Masaki, Sara E. Williford, Paul Ingravallo, Zongdi Feng, Frederick Lahser, Ernest Asante‐Appiah, Petra Neddermann, Raffaele De Francesco, A Howe, Stanley M. Lemon

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV Genotype 1a Replicons

    The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV G... mā Frederick Lahser, Karin Bystol, Stephanie Curry, Patricia McMonagle, Ellen Xia, Paul Ingravallo, Robert A. Chase, Rong Liu, Todd A. Black, Daria J. Hazuda, Anita Y. M. Howe, Ernest Asante‐Appiah

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    <i>In Vitro</i>Characterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor

    <i>In Vitro</i>Characterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor mā Ming‐Tain Lai, Meizhen Feng, Jean‐Pierre Falgueyret, Paul Tawa, Marc Witmer, Daniel J. DiStefano, Yuan Li, Jason D. Burch, Nancy A. Sachs, Meiqing Lu, Elizabeth Cauchon, Louis‐Charles Campeau, Jay A. Grobler, Youwei Yan, Yves Ducharme, Bernard Côté, Ernest Asante‐Appiah, Daria J. Hazuda, Michael D. Miller

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers

    Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers mā I‐Ming Wang, Bin Zhang, Xia Yang, Jun Zhu, Serguei Stepaniants, Chunsheng Zhang, Qingying Meng, Mette A. Peters, Yudong D. He, Chester Ni, Deborah Slipetz, Michael A. Crackower, Hani Houshyar, Christopher M. Tan, Ernest Asante‐Appiah, Gary P. O’Neill, Mingjuan Luo, Rolf Thieringer, Jeffrey Yuan, Chi‐Sung Chiu, Pek Yee Lum, John R. Lamb, Yves Boie, Hilary Wilkinson, Eric E. Schadt, Hongyue Dai, Christopher J. Roberts

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Polymorphisms

    Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Polymorphisms mā Ling Tong, Wensheng Yu, Lei Chen, Oleg Selyutin, Michael P. Dwyer, Anilkumar G. Nair, Robert Mazzola, Jae‐Hun Kim, Deyou Sha, Jingjun Yin, Rebecca T. Ruck, Ian W. Davies, Bin Hu, Bin Zhong, Jinglai Hao, Tao Ji, Shuai Zan, Rong Liu, Sony Agrawal, Ellen Xia, Stephanie Curry, Patricia McMonagle, Karin Bystol, Frederick Lahser, Donna Carr, Laura L. Rokosz, Paul Ingravallo, Shiying Chen, Kung‐I Feng, Mark E. Cartwright, Ernest Asante‐Appiah, Joseph A. Kozlowski

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: